Pricing Log in Create free account
Saturday 17 October 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%
Market cap
$10.9B
P/E
19.8×
Fwd P/E
28.7×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

The Cooper Companies, Inc. (COO) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, The Cooper Companies, Inc. (COO) trades at a EV/EBITDA of 14.6×. Over the past ten years it has ranged from 13.1× (April 2026) to 35.0× (April 2021); the current reading is higher than 3% of that period. That is in line with the Medical Instruments & Supplies industry median of 14.6× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 15.4× (28.62%)
FY2024 21.6× 8.64%
FY2023 19.8× 5.09%
FY2022 18.9× (30.51%)
FY2021 27.2× (6.56%)
FY2020 29.1× 49.34%
FY2019 19.5× (9.73%)
FY2018 21.6× 3.79%
FY2017 20.8× 11.12%
FY2016 18.7× (9.41%)

Quarterly newest first

Period EV/EBITDA Change
Jul 2026 17.6× 6.56%
Apr 2026 16.5× (0.32%)
Jan 2026 16.6× 7.77%
Oct 2025 15.4× 3.96%
43 more quarters

Against its own ten years

Low 13.1× High 35.0×
Ten-year median 21.7×
Current reading's percentile 3

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation compare 7.6×
ATR AptarGroup, Inc. compare 11.6×
ALGN Align Technology, Inc. compare 11.8×
BAX Baxter International Inc. compare 14.0×
BLCO Bausch + Lomb Corporation compare 14.1×
COO The Cooper Companies, Inc. 14.6×
TFX Teleflex Incorporated compare 32.0×
RGEN Repligen Corporation compare 60.2×
AVTR Avantor, Inc. compare 116×
Medical Instruments & Supplies industry median 14.6×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on COO